Background
Background There is growing There is growing evidence of a relationship between frontal evidence of a relationship between frontal neuroimaging and neuropsychological neuroimaging and neuropsychological abnormalities and the physiopathology abnormalities and the physiopathology and course of late-onset major and course of late-onset major depression. depression.
Aims Aims To assess acute antidepressant
To assess acute antidepressant response in late-onset major depression in response in late-onset major depression in relation to baseline frontal perfusion relation to baseline frontal perfusion ratios. ratios.
Method Method A
A 99m 99m Tc HMPAO single Tc HMPAO single photon emission computed tomographic photon emission computed tomographic brain scan was performed in medication-brain scan was performed in medicationfree patients with late-onset major free patients with late-onset major depression, who were then included in a depression, who were then included in a 12-week antidepressanttreatment 12-week antidepressanttreatment regimen.Logistic regression was used to regimen.Logistic regression was used to define a predictive model of non-define a predictive model of nonremission. remission.
Results
Results Atotal of 47 patients Atotal of 47 patients completed the study, 34 of whom were completed the study, 34 of whom were classed as remitters and13 as non-classed as remitters and13 as nonremitters.The variableleft anterior fronto-remitters.The variableleft anterior frontocerebellar perfusion ratio had a global cerebellar perfusion ratio had a global predictive power of 87%. Analysing this predictive power of 87%. Analysing this variable together with the baseline variable together with the baseline variables age of onset and duration of variables age of onset and duration of index episode, the predictive power ofthe index episode, the predictive power ofthe model rose to 94%. model rose to 94%.
Conclusions Conclusions Our study suggests that a
Our study suggests that a specific frontal functioning could predict specific frontal functioning could predict the acute antidepressant response in late-the acute antidepressant response in lateonset severe major depression. onset severe major depression.
Declaration of interest Declaration of interest None.
None.
Neuropsychological studies (Alexopoulos Neuropsychological studies (Alexopoulos et al et al, 2000) , structural neuroimaging studies , 2000), structural neuroimaging studies (Alexopoulos (Alexopoulos et al et al, 2002) and functional , 2002) and functional neuroimaging studies (Kumar neuroimaging studies (Kumar et al et al, 2002; , 2002; Navarro Navarro et al et al, 2002) have suggested the , 2002) have suggested the possible involvement of the frontal lobes possible involvement of the frontal lobes in the physiopathology of late-onset major in the physiopathology of late-onset major depression. Various structural neuroimaging depression. Various structural neuroimaging studies have stressed the possible influence studies have stressed the possible influence of these frontal alterations on the course of these frontal alterations on the course of the disorder (Simpson of the disorder (Simpson et al et al, 1998; , 1998; Alexopoulos Alexopoulos et al et al, 2002) . To our knowl-, 2002) . To our knowledge, no prognostic study as yet has used edge, no prognostic study as yet has used functional neuroimaging. Following on from functional neuroimaging. Following on from the vascular depression concept defined by the vascular depression concept defined by Alexopoulos Alexopoulos et al et al (1997) , the hypothesis (1997), the hypothesis we put forward here is that the greater the we put forward here is that the greater the frontal hypoperfusion, the poorer the frontal hypoperfusion, the poorer the clinical evolu clinical evolution of late-onset major tion of late-onset major depression. After depression. After establishing in an earlier establishing in an earlier study (Navarro study (Navarro et al et al, 2002) that perfusion , 2002) that perfusion abnormalities detected during active abnormalities detected during active depression in elderly patients in the left depression in elderly patients in the left anterior frontal region disappeared in re-anterior frontal region disappeared in remission, the main aim of our study was to mission, the main aim of our study was to assess in a new sample the acute response assess in a new sample the acute response to antidepressant medication of patients to antidepressant medication of patients with late-onset major depression in relation with late-onset major depression in relation to baseline frontal perfusion ratios. to baseline frontal perfusion ratios.
METHOD METHOD

Sample Sample
The study was conducted at the Hospital The study was conducted at the Hospital Clınic of Barcelona. Participants were re-Clínic of Barcelona. Participants were recruited from in-patients and out-patients cruited from in-patients and out-patients with a diagnosis of major depressive dis-with a diagnosis of major depressive disorder, aged 60 years or over; all were order, aged 60 years or over; all were right-handed. Only people with late-onset right-handed. Only people with late-onset depression were included, i.e. those in depression were included, i.e. those in whom depression had begun after the age whom depression had begun after the age of 50. To be eligible for inclusion, patients of 50. To be eligible for inclusion, patients had to fulfil the had to fulfil the DSM-IV (American DSM-IV (American Psychiatric Association, Psychiatric Association, 1994) criteria for 1994) criteria for a current major depressive episode. We a current major depressive episode. We excluded patients with neurological dis-excluded patients with neurological disorders, those receiving medications with orders, those receiving medications with potential central nervous system side-effects potential central nervous system side-effects and those with uncontrolled medical illness and those with uncontrolled medical illness at the time of recruitment. Psychiatric at the time of recruitment. Psychiatric exclusion criteria included any history of exclusion criteria included any history of mania, hypomania or non-affective psy-mania, hypomania or non-affective psychosis, and current chosis, and current substance dependence. substance dependence. Similarly, in order to Similarly, in order to reduce the risk that reduce the risk that prior exposure to electroconvulsive therapy prior exposure to electroconvulsive therapy (ECT) might bias the results, we excluded (ECT) might bias the results, we excluded patients who had patients who had received ECT within 6 received ECT within 6 months of recruitment. months of recruitment.
The study was approved by the ethical The study was approved by the ethical committee of our hospital. All patients (or committee of our hospital. All patients (or a close relative when there was doubt about a close relative when there was doubt about the patient's understanding) gave informed the patient's understanding) gave informed written consent. written consent.
Clinical assessment Clinical assessment
Depressive symptoms were rated on the Depressive symptoms were rated on the , 1965) . All patients recruited had a baseline HRSD patients recruited had a baseline HRSD score of 21 or greater. A baseline Newcastle score of 21 or greater. A baseline Newcastle Scale score of 7 or higher was used to define Scale score of 7 or higher was used to define endogenous depression. We also screened endogenous depression. We also screened for reduced global cognitive function using for reduced global cognitive function using the , 1975; Lobo 1975; Lobo et al et al, 1999) . , 1999). Following Baldwin & Tomenson Following Baldwin & Tomenson (1995) , we quantified vascular risk factors (1995), we quantified vascular risk factors as follows: 0, absent; 1, mild (asympto-as follows: 0, absent; 1, mild (asymptomatic), for example, controlled hypertension matic), for example, controlled hypertension or clinical evidence of arteriosclerosis (e.g. or clinical evidence of arteriosclerosis (e.g. carotid murmur); 2, moderate (sympto-carotid murmur); 2, moderate (symptomatic), for example, poorly controlled matic), for example, poorly controlled hypertension, symptomatic angina or history hypertension, symptomatic angina or history of myocardial infarction; and 3, severe of myocardial infarction; and 3, severe (active disease), for example, peripheral vas-(active disease), for example, peripheral vascular disease with amputation or transient cular disease with amputation or transient ischaemic attack. Other vascular risk factors ischaemic attack. Other vascular risk factors such as blood levels of cholesterol and such as blood levels of cholesterol and glucose were also assessed. glucose were also assessed.
Study design Study design
To minimise bias from the administration To minimise bias from the administration of psychotropic drugs, patients underwent of psychotropic drugs, patients underwent a minimum washout period of 10 days for a minimum washout period of 10 days for antidepressant medication and a minimum antidepressant medication and a minimum of 2 days for benzodiazepine medication. of 2 days for benzodiazepine medication. Baseline clinical assessments, including Baseline clinical assessments, including brain single photon emission computed brain single photon emission computed tomography (SPECT), were then con-tomography (SPECT), were then conducted. After the SPECT scan, treatment ducted. After the SPECT scan, treatment was started. Fortnightly clinical evaluations was started. Fortnightly clinical evaluations (HRSD) were made during the study. (HRSD) were made during the study.
Evaluators were masked to the functional Evaluators were masked to the functional neuroimaging measures. Patients were neuroimaging measures. Patients were considered to be in remission when the considered to be in remission when the 17-item HRSD score was below 8 on two 17-item HRSD score was below 8 on two consecutive visits. consecutive visits.
Treatment protocol Treatment protocol
The treatment used complied with standard The treatment used complied with standard therapeutic norms, and specifically with therapeutic norms, and specifically with our hospital's treatment protocol for our hospital's treatment protocol for elderly patients with major depression. elderly patients with major depression. The antidepressant initially used was The antidepressant initially used was nortriptyline at a daily dosage of 12.5 mg, nortriptyline at a daily dosage of 12.5 mg, which was raised to 25 mg and then which was raised to 25 mg and then 50 mg on the fourth and eighth day of 50 mg on the fourth and eighth day of treatment, respectively. Nortriptyline treatment, respectively. Nortriptyline plasma concentrations were determined plasma concentrations were determined after 1 week of stable dosing; the dose after 1 week of stable dosing; the dose was adjusted to obtain a blood level was adjusted to obtain a blood level between 80 ng/ml and 120 ng/ml (304-between 80 ng/ml and 120 ng/ml (304-456 nmol/l); maximum dose 100 mg/day. 456 nmol/l); maximum dose 100 mg/day. All patients achieved correct plasma levels All patients achieved correct plasma levels during the first month of treatment. In during the first month of treatment. In combination with antidepressant treat-combination with antidepressant treatment, both haloperidol (up to 4 mg/day ment, both haloperidol (up to 4 mg/day for management of psychotic symptoms) for management of psychotic symptoms) and lorazepam (up to 4 mg/day for manage-and lorazepam (up to 4 mg/day for management of anxiety/insomnia) were allowed. ment of anxiety/insomnia) were allowed.
Patients remained on a regimen of Patients remained on a regimen of nortriptyline for 12 weeks. Patients whose nortriptyline for 12 weeks. Patients whose HRSD score had not fallen by at least HRSD score had not fallen by at least 50% by the end of the sixth week of 50% by the end of the sixth week of nortriptyline treatment received adjunctive nortriptyline treatment received adjunctive citalopram (20 mg/day) until the end of citalopram (20 mg/day) until the end of the 12-week follow-up. the 12-week follow-up.
SPECT procedure SPECT procedure
At the end of the drug wash-out period, each At the end of the drug wash-out period, each participant underwent a participant underwent a 99m 99m -technetium -technetium hexamethylpropylene amine oxime ( hexamethylpropylene amine oxime ( 99m 99m Tc-Tc-HMPAO) SPECT brain scan. The scan HMPAO) SPECT brain scan. The scan was performed using a rotating dual-head was performed using a rotating dual-head gamma camera (Helix, General Electric gamma camera (Helix, General Electric Medical Systems), fitted with a high-Medical Systems), fitted with a highresolution fanbeam collimator. Data acqui-resolution fanbeam collimator. Data acquisition started 20 min after intravenous sition started 20 min after intravenous injection of 740 MBq injection of 740 MBq 99m 99m Tc-HMPAO Tc-HMPAO (Ceretec; Nycomed, Amersham, UK). Sixty (Ceretec; Nycomed, Amersham, UK). Sixty 30 s frames were collected in a 360 30 s frames were collected in a 3608 8 circular circular orbit, step and shoot mode, using a orbit, step and shoot mode, using a 128 1286 6128 matrix.
128 matrix. Image data were processed on an Image data were processed on an Elscint SP1 computer (Apex SP-X, software Elscint SP1 computer (Apex SP-X, software version 3.12). Reconstruction was per-version 3.12). Reconstruction was performed by filtered back-projection using a formed by filtered back-projection using a Metz filter (power factor 3). No attenu-Metz filter (power factor 3). No attenuation correction was performed. The final ation correction was performed. The final pixel size was 3.9 mm and the full width pixel size was 3.9 mm and the full width at half-maximum in the transaxial plane at half-maximum in the transaxial plane was 10 mm. Semi-quantitative regional was 10 mm. Semi-quantitative regional cerebral blood flow analysis was performed cerebral blood flow analysis was performed using irregular regions of interest (ROIs) using irregular regions of interest (ROIs) stored in the computer as a stored in the computer as a T T 1 1 -weighted -weighted magnetic resonance imaging (MRI) tem-magnetic resonance imaging (MRI) template. Brain SPECT images were normal-plate. Brain SPECT images were normalised to the standard ised to the standard T T 1 1 -weighted MRI.
-weighted MRI. The ROIs were placed in ten 7.8-mm-thick The ROIs were placed in ten 7.8-mm-thick oblique slices, which were parallel to the oblique slices, which were parallel to the fronto-cerebellar plane. For each hemi-fronto-cerebellar plane. For each hemisphere, anterior fronto-cerebellar ratios sphere, anterior fronto-cerebellar ratios were obtained as 100 were obtained as 1006 6mean counts per mean counts per pixel of anterior frontal ROIs divided by pixel of anterior frontal ROIs divided by the mean counts per pixel of cerebellar the mean counts per pixel of cerebellar ROIs. Using the same formula, the pos-ROIs. Using the same formula, the posterior fronto-cerebellar ratios were also terior fronto-cerebellar ratios were also obtained. The nuclear medicine physician obtained. The nuclear medicine physician was masked to the 12-week course. was masked to the 12-week course.
Statistical procedures Statistical procedures
Comparisons between groups were assessed Comparisons between groups were assessed by using the Student's by using the Student's t t-test (or the Mann--test (or the Mann-Whitney Whitney U U-test for non-parametric data) -test for non-parametric data) for continuous variables and the chi-for continuous variables and the chisquared test for discrete variables. The squared test for discrete variables. The Kolmogorov-Smirnov test was applied to Kolmogorov-Smirnov test was applied to assess the normality of the continuous vari-assess the normality of the continuous variables. The level of statistical significance ables. The level of statistical significance was set at was set at P P5 50.05. 0.05. Logistic regression methods were used to Logistic regression methods were used to define a predictive model of non-remission. define a predictive model of non-remission. In the first stage, only the frontal In the first stage, only the frontal perfusion measures were assessed. In the perfusion measures were assessed. In the second stage, the baseline functional neuro-second stage, the baseline functional neuroimaging variables and the baseline clinical imaging variables and the baseline clinical and demographic variables were assessed and demographic variables were assessed jointly to improve the model. Different jointly to improve the model. Different models were obtained and explored by models were obtained and explored by forward selection, backward selection and forward selection, backward selection and stepwise regression. The most significant stepwise regression. The most significant variables were then fixed in the model and variables were then fixed in the model and the others were introduced progressively to the others were introduced progressively to improve the adjustment. The model improve the adjustment. The model calibration was assessed by the Hosmer-calibration was assessed by the Hosmer-Lemeshow goodness-of-fit test. Finally, the Lemeshow goodness-of-fit test. Finally, the reliability and precision of each model were reliability and precision of each model were analysed in order to choose the best final analysed in order to choose the best final solution (Domenech, 1999) . solution (Doménech, 1999) .
To avoid any possible separation be-To avoid any possible separation between groups confounding the results, the tween groups confounding the results, the predictive models were assessed further by predictive models were assessed further by using a split-half approach. To try to avoid using a split-half approach. To try to avoid an unlucky splitting of the samples that an unlucky splitting of the samples that would cause some variables to be absent would cause some variables to be absent in certain groups, the following approach in certain groups, the following approach was adopted. The whole sample was split was adopted. The whole sample was split randomly into two groups, A and B. To randomly into two groups, A and B. To increase the possibility that the data-sets increase the possibility that the data-sets to be analysed covered the complete to be analysed covered the complete variation, two more groups were generated, variation, two more groups were generated, C and D. Group C was made from the first C and D. Group C was made from the first half of A and B, and group D from the last half of A and B, and group D from the last half of A and B. Every model was fitted to half of A and B. Every model was fitted to each of the data-sets. If the solution each of the data-sets. If the solution replicates over sets A and B or over sets C replicates over sets A and B or over sets C and D, the possibility of empirical verifica-and D, the possibility of empirical verification of correctness of the solution (i.e. that tion of correctness of the solution (i.e. that the model captures essential variation not the model captures essential variation not only pertaining to the specific samples) is only pertaining to the specific samples) is increased. By contrast, although the ab-increased. By contrast, although the absence of stability of some components sence of stability of some components across subsamples might reflect its presence across subsamples might reflect its presence only in specific subsets, this finding only in specific subsets, this finding increases the probability that the model will increases the probability that the model will not be valid. not be valid.
Finally, for further clarification of our Finally, for further clarification of our findings in a clinical sense, the receiver findings in a clinical sense, the receiver operating characteristic (ROC) curve was operating characteristic (ROC) curve was measured for each continuous variable to measured for each continuous variable to define the cut-off point with the best define the cut-off point with the best sensitivity and specificity. sensitivity and specificity.
RESULTS RESULTS
The initial sample comprised 52 patients, The initial sample comprised 52 patients, five of whom were eventually excluded: five of whom were eventually excluded: one had died, two did not attend scheduled one had died, two did not attend scheduled follow-up visits, and two required ECT follow-up visits, and two required ECT because of severe clinical deterioration. because of severe clinical deterioration. The final sample therefore comprised 47 The final sample therefore comprised 47 patients. patients.
The Kolmogorov-Smirnov test showed The Kolmogorov-Smirnov test showed that three variables (MMSE score, Newcastle that three variables (MMSE score, Newcastle Scale score and the previous evolution in Scale score and the previous evolution in years) did not adjust to a normal distribu-years) did not adjust to a normal distribution. It was possible to calculate a logarith-tion. It was possible to calculate a logarithmic transformation of the Newcastle score mic transformation of the Newcastle score for adjustment to a normal distribution. It for adjustment to a normal distribution. It was not possible to transform the MMSE was not possible to transform the MMSE score or the years of previous evolution score or the years of previous evolution for adjustment to a normal distribution. for adjustment to a normal distribution.
The mean age was 74. (23%). Of the 47 patients who completed the Of the 47 patients who completed the study, 34 were classed as 'remitters' and study, 34 were classed as 'remitters' and 13 as 'non-remitters'. Some clinical data 13 as 'non-remitters'. Some clinical data for both subgroups are presented in Table  for both subgroups are presented in Table  1 . Significant differences between the sub-1. Significant differences between the subgroups were found in the variables duration groups were found in the variables duration of current episode, Newcastle score, left of current episode, Newcastle score, left anterior frontal ratio (LAFR) and right anterior frontal ratio (LAFR) and right anterior frontal ratio. No significant differ-anterior frontal ratio. No significant difference was found in other clinical variables ence was found in other clinical variables such as age of onset, age of index episode such as age of onset, age of index episode or presence of vascular risk factors, or in or presence of vascular risk factors, or in neuroimaging variables such as left and neuroimaging variables such as left and right posterior frontal ratios (Table 1) . right posterior frontal ratios (Table 1) . .92) and the predictions showed 0.92) and the predictions showed good sensitivity (76.9%) and specificity good sensitivity (76.9%) and specificity (91.2%). The global predictive power was (91.2%). The global predictive power was 87.2%. The inclusion of the LAFR 87.2%. The inclusion of the LAFR indicated that the risk of non-remission indicated that the risk of non-remission at at 3-month follow-up rose almost 2.5 times 3-month follow-up rose almost 2.5 times with every point that the LAFR increased with every point that the LAFR increased (exp(B) (exp(B)¼2.54; 95% CI 1.5-4.32). In the 2.54; 95% CI 1.5-4.32). In the split-half approach, the only variable enter-split-half approach, the only variable entering the four subsamples was the LAFR. The ing the four subsamples was the LAFR. The solution was found to be replicated over solution was found to be replicated over subsets (Table 2) . subsets ( Table 2) .
The ROC curve measurement for the The ROC curve measurement for the LAFR showed that the best cut-off point LAFR showed that the best cut-off point was a ratio value of 95.5 (sensitivity was a ratio value of 95.5 (sensitivity 92.3%; specificity 88.2%); area under the 92.3%; specificity 88.2%); area under the curve curve¼0.95; 95% CI 0.89-1; 0.95; 95% CI 0.89-1; P P5 50.01). 0.01).
Global predictive model Global predictive model of non-remission of non-remission
To improve the predictive model, the ¼0.832), its goodness of fit was 0.832), its goodness of fit was 3 0 8 3 0 8 .99) and 0.99) and its predictions showed good sensitivity its predictions showed good sensitivity (92.3%) and specificity (94.1%). The (92.3%) and specificity (94.1%). The global predictive power was 93.6%. global predictive power was 93.6%.
The most determinant variable was the The most determinant variable was the LAFR. The risk of non-remission at 3-LAFR. The risk of non-remission at 3month follow-up rose almost sixfold for month follow-up rose almost sixfold for each point that the LAFR increased each point that the LAFR increased (exp(B) (exp(B)¼5.65; 95% CI 1.41-22.61). The 5.65; 95% CI 1.41-22.61). The second variable entering the final model second variable entering the final model was the current episode duration, indicat-was the current episode duration, indicating that the risk of non-remission increased ing that the risk of non-remission increased almost fourfold for every extra month in almost fourfold for every extra month in the current episode duration (exp(B) the current episode duration (exp(B)¼3.81; 3.81; 3.81; 95% CI 1.12-12.93). In the split-half 3.81; 95% CI 1.12-12.93). In the split-half approach, the only variable entering the approach, the only variable entering the four subsamples was again the LAFR. The four subsamples was again the LAFR. The solution including the clinical variables solution including the clinical variables was not replicated over subsets (Table 3) . was not replicated over subsets (Table 3) .
The best cut-off point for current epi-The best cut-off point for current episode duration according to the ROC curve sode duration according to the ROC curve measurement was 2.5 months (sensitivity measurement was 2.5 months (sensitivity 84.6%; specificity 55.9%; area under the 84.6%; specificity 55.9%; area under the curve curve¼0.76; 95% CI 0.61-0.9; 0.76; 95% CI 0.61-0.9; P P¼0.007). 0.007).
DISCUSSION DISCUSSION
The main findings of this study are that:
(a) The LAFR seems to be able to predict (a) The LAFR seems to be able to predict response to acute pharmacological response to acute pharmacological treatment in late-onset major depression. treatment in late-onset major depression.
(b) Adding baseline clinical variables, dura-(b) Adding baseline clinical variables, duration of index episode and current age to tion of index episode and current age to the LAFR in the statistical analysis the LAFR in the statistical analysis seems to increase the model's predictive seems to increase the model's predictive power. However, these results are not power. However, these results are not confirmed by the split-half approach, confirmed by the split-half approach, and could be due to the sample and could be due to the sample characteristics. characteristics.
Variables predicting outcome Variables predicting outcome
Our results suggest that the risk of non-Our results suggest that the risk of nonremission at 3-month follow-up increases remission at 3-month follow-up increases almost 2.5 times with each extra point in almost 2.5 times with each extra point in the LAFR. The cut-off point of 95.5 pre-the LAFR. The cut-off point of 95.5 predicts with an acceptable sensitivity and dicts with an acceptable sensitivity and specificity the remission/non-remission specificity the remission/non-remission of the depressive episode after 3 months of the depressive episode after 3 months of pharmacological treatment. Unlike of pharmacological treatment. Unlike structural structural neuroimaging studies of patients neuroimaging studies of patients with late-onset major depression, which with late-onset major depression, which have described an association between have described an association between frontal structural alterations and response frontal structural alterations and response to treatment (Simpson to treatment (Simpson et al et al, 1998; , 1998; Alexopoulos Alexopoulos et al et al, 2002) , to our knowledge , 2002), to our knowledge this is the first functional neuroimaging this is the first functional neuroimaging study to report an association between study to report an association between cerebral perfusion and response to cerebral perfusion and response to pharmacological treatment in this subgroup pharmacological treatment in this subgroup of patients with depression. The stability of of patients with depression. The stability of the SPECT variable for predicting the the SPECT variable for predicting the therapeutic outcome across the split-half therapeutic outcome across the split-half approach increases the possibility of approach increases the possibility of correctness of the model. correctness of the model. Furthermore, in our study, the addition Furthermore, in our study, the addition of the duration of the index episode and of the duration of the index episode and current age seemed to increase the model's current age seemed to increase the model's predictive ability. However, taking into predictive ability. However, taking into account that these results were not con-account that these results were not confirmed in the split-half approach, the firmed in the split-half approach, the absence of stability of some clinical compo-absence of stability of some clinical components across subgroups increases the prob-nents across subgroups increases the probability that the model will not be valid ability that the model will not be valid and challenges the conclusions obtained and challenges the conclusions obtained from its use. In either case, further studies from its use. In either case, further studies applying the same applying the same models on an entirely models on an entirely different data-set are required to confirm different data-set are required to confirm our findings. our findings.
The possible association between The possible association between the clinical variables, duration of index the clinical variables, duration of index episode and current age, and course episode and current age, and course of the illness has been assessed in a of the illness has been assessed in a number of studies, but the results are number of studies, but the results are inconsistent. Like us, a number of authors inconsistent. Like us, a number of authors have found a correlation between older have found a correlation between older age at the time of the index episode and age at the time of the index episode and poor response to treatment (Kennedy poor response to treatment (Kennedy et al et al, 1991; Dew , 1991; Dew et al et al, 1997 Dew et al et al, ), although , 1997 , although the results of other studies have not the results of other studies have not corroborated this claim (Burvill corroborated this claim (Burvill et al et al, , 1991; Tuma, 1996; Halloran 1991; Tuma, 1996; Halloran et al et al, 1999; , 1999; Bosworth Bosworth et al et al, 2002) . Equally, our finding , 2002). Equally, our finding of a correlation between longer duration of of a correlation between longer duration of current episode and poorer response to current episode and poorer response to treatment is in agreement with some earlier treatment is in agreement with some earlier studies (Murphy, 1983; Tuma, 1996; studies (Murphy, 1983; Tuma, 1996; Halloran Halloran et al et al, 1999) , but not with others , 1999), but not with others (Burvill (Burvill et al et al, 1991; Kennedy , 1991; Kennedy et al et al, 1991; , 1991; Dew Dew et al et al, 1997; Bosworth , 1997; Bosworth et al et al, 2002 Bosworth et al et al, ). , 2002 . This lack of consensus is probably caused This lack of consensus is probably caused by the wide range of methodological by the wide range of methodological approaches, statistical analyses and demo-approaches, statistical analyses and demographic characteristics of the samples in graphic characteristics of the samples in these studies. these studies.
Regarding other clinical variables, it Regarding other clinical variables, it should be emphasised that the existence of should be emphasised that the existence of significant differences in the Newcastle significant differences in the Newcastle Scale scores between remitters and non-Scale scores between remitters and nonremitters (higher scores among remitters; remitters (higher scores among remitters; Table 1 ) seems consistent with most of Table 1 ) seems consistent with most of the previous studies suggesting higher the previous studies suggesting higher rates of response to acute anti-rates of response to acute antidepressive treatment in patients with endo-depressive treatment in patients with endogenous depression compared with patients genous depression compared with patients with non-endogenous depression (Nelson with non-endogenous depression (Nelson & Charney, 1980; Schatzberg, 1999) . At & Charney, 1980; Schatzberg, 1999) . At this point, it is not possible to know this point, it is not possible to know whether increasing the size of our study whether increasing the size of our study sample would have sample would have incorporated the incorporated the Newcastle clinical variable Newcastle clinical variable in the global in the global predictive model. predictive model. 3 0 9 3 0 9 
Significance of frontal perfusion Significance of frontal perfusion abnormalities in late-onset abnormalities in late-onset major depression major depression
It is not easy to explain why the lower the It is not easy to explain why the lower the LAFR (i.e. the higher the left anterior LAFR (i.e. the higher the left anterior frontal hypoperfusion) the better the rates frontal hypoperfusion) the better the rates of clinical remission. It could be that the of clinical remission. It could be that the LAFR reflects only the speed of response LAFR reflects only the speed of response to pharmacological treatment and not to pharmacological treatment and not remission/non-remission. A longer follow-remission/non-remission. A longer followup of the patients, especially bearing in up of the patients, especially bearing in mind the evidence that geriatric patients mind the evidence that geriatric patients might take longer to respond to anti-might take longer to respond to antidepressant treatment (Mulsant & Pollock, depressant treatment (Mulsant & Pollock, 1998; Reynolds 1998; Reynolds et al et al, 1996 Reynolds et al et al, ), would provide , 1996 , would provide more information on this issue. It is diffi-more information on this issue. It is difficult to establish the histological and clinical cult to establish the histological and clinical significance of the cut-off point described; significance of the cut-off point described; in any case, we believe that its significance in any case, we believe that its significance lies in its usefulness as a prognostic factor lies in its usefulness as a prognostic factor and as a variable in the area of research. and as a variable in the area of research.
We should stress that the direction of We should stress that the direction of the prediction is at the very least surprising, the prediction is at the very least surprising, especially as the few descriptive studies especially as the few descriptive studies using functional neuroimaging to investi-using functional neuroimaging to investigate acute major depression in the elderly gate acute major depression in the elderly have obtained inconsistent results (Ebmeier have obtained inconsistent results (Ebmeier et al et al, 1998; , 1998; Halloran Halloran et al et al, 1999; Navarro , 1999; Navarro et et al al, 2002 Navarro et et al al, ). , 2002 . These inconsistencies suggest that These inconsistencies suggest that the alterations in frontal perfusion in this the alterations in frontal perfusion in this disorder are not specific. disorder are not specific.
The frontal functioning neuroimaging The frontal functioning neuroimaging results of our study do not support our results of our study do not support our initial hypothesis and therefore do not cor-initial hypothesis and therefore do not corroborate the proposal of Alexopoulos roborate the proposal of Alexopoulos et al et al (1997) of a degenerative ischaemic process (1997) of a degenerative ischaemic process as the cause of late-onset major depression as the cause of late-onset major depression (vascular depression). Our hypothesis was (vascular depression). Our hypothesis was that the greater the frontal hypoperfusion that the greater the frontal hypoperfusion (supposedly a manifestation of cerebral (supposedly a manifestation of cerebral ischaemia), the lower would be the level ischaemia), the lower would be the level of clinical reversibility (that is, a lower rate of clinical reversibility (that is, a lower rate of remitters). This study found the reverse of remitters). This study found the reverse to be the case. to be the case.
To explain this unexpected result, we To explain this unexpected result, we could state that most studies of vascular could state that most studies of vascular depression are associative (O'Brien depression are associative (O'Brien et al et al, , 1996; Greenwald 1996; Greenwald et al et al, 1998) rather than , 1998) rather than causative, and it is possible that the causative, and it is possible that the frequently observed association between frequently observed association between late-onset major depression and vascular late-onset major depression and vascular disease could in fact be the result of un-disease could in fact be the result of unknown confounding factors. A vascular known confounding factors. A vascular aetiology has been proposed for late-onset aetiology has been proposed for late-onset depression on the strength of the presence depression on the strength of the presence of hyperintensities, although the physio-of hyperintensities, although the physiopathological bases of these lesions have pathological bases of these lesions have not been determined definitively in patients not been determined definitively in patients with major depression (Thomas with major depression (Thomas et al et al, , 2002) . We should add that this is not the 2002). We should add that this is not the first study to obtain results that challenge first study to obtain results that challenge the degenerative vascular hypothesis for the degenerative vascular hypothesis for late-onset major depression (Dupont late-onset major depression (Dupont et al et al, , 1995; Ebmeier 1995; Ebmeier et al et al, 1997; Greenwald , 1997; Greenwald et al et al, 1998; Navarro , 1998; Navarro et al et al, 2002) . Nonethe-, 2002) . Nonetheless, we should stress that the inferences less, we should stress that the inferences made in this section, i.e. that our results made in this section, i.e. that our results do not support the vascular depression do not support the vascular depression hypothesis, are based on the possible but hypothesis, are based on the possible but unproven association between brain SPECT unproven association between brain SPECT alteration and ischaemia. This association alteration and ischaemia. This association is debatable, given the absence of conclu-is debatable, given the absence of conclusive studies that support its existence in sive studies that support its existence in major depression. major depression.
Our results suggest that the pattern of Our results suggest that the pattern of left anterior frontal perfusion reflects a left anterior frontal perfusion reflects a primary alteration of neuronal activity, primary alteration of neuronal activity, probably reversible, and that there might probably reversible, and that there might not necessarily be a primary vascular sub-not necessarily be a primary vascular substrate. Equally, although future studies strate. Equally, although future studies should test the predictive models obtained should test the predictive models obtained here, this report provides strong evidence here, this report provides strong evidence in favour of the existence of specific neuro-in favour of the existence of specific neurofunctional predictors of the course in late-functional predictors of the course in lateonset severe major depression. onset severe major depression.
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